The effects of nadolol on various cardiac tissues in normoxia, and on atrial muscle in simulated ischaemia

This publication has 18 references indexed in Scilit:

• EFFECTS ON RABBIT NODAL, ATRIAL, VENTRICULAR AND PURKINJE CELL POTENTIALS OF A NEW ANTIARRHYTHMIC DRUG, CIBENZOLINE, WHICH PROTECTS AGAINST ACTION POTENTIAL SHORTENING IN HYPOXIA
  British Journal of Pharmacology, 1982
• Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man.
  Heart, 1981
• Timolol after myocardial infarction: an answer or a new set of questions?
  BMJ, 1981
• The effects of various fatty acids on action potential shortening during sequential periods of ischaemia and reperfusion
  Journal of Molecular and Cellular Cardiology, 1980
• Effect of intravenous propranolol on QT interval. A new method of assessment.
  Heart, 1980
• Metabolic Studies in Patients with Nadolol: Oral and Intravenous Administration
  The Journal of Clinical Pharmacology, 1977
• The effects of palmitate on intracellular potentials recorded from langendorff-perfused guinea-pig hearts in normoxia and hypoxia, and during perfusion at reduced rate of flow
  Journal of Molecular and Cellular Cardiology, 1977
• Cardiac Purkinje fibres
  Pflügers Archiv - European Journal of Physiology, 1977
• Pharmacology of nadolol (SQ 11725), a β-adrenergic antagonist lacking direct myocardial depression
  European Journal of Pharmacology, 1975
• The relevance of β‐receptor blockade to ouabain‐induced cardiac arrhythmias
  British Journal of Pharmacology, 1969